After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Atyr Pharma Inc is $94.07M. A total of 3.6 million shares were traded on the day, compared to an average of 11.18M shares.
In the most recent transaction, SCHIMMEL PAUL bought 682,001 shares of ATYR for 0.90 per share on Oct 08 ’25. After the transaction, the Director now owns 1,095,024 company shares. In a previous transaction on Oct 09 ’25, SCHIMMEL PAUL bought 317,999 shares at 0.94 per share. ATYR shares that Director owns now total 1,413,023.
Among the insiders who bought shares, Gross Jane A acquired of 3,750 shares on Mar 17 ’25 at a per-share price of $4.00. This resulted in the Director holding 9,750 shares of ATYR after the transaction. In another insider transaction, Broadfoot Jill Marie sold 1,254 shares at $3.78 per share on Feb 04 ’25. Company shares held by the Chief Financial Officer now total 31,763.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ATYR has a high of $7.29 and a low of $0.68.
As of this writing, ATYR has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.23. The company reported an EPS of -$0.23 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ATYR’s latest balance sheet shows that the firm has $107.91M in Cash & Short Term Investments as of fiscal 2021. There were $1.38M in debt and $6.01M in liabilities at the time. Its Book Value Per Share was $0.81, while its Total Shareholder’s Equity was $109.13M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATYR is Buy with a score of 3.44.
